Clinuvel PharmaceuticalsCUV 
$9.82-0.67%24h
-0.67%24h
Global rank11476
Market cap$485.22M
Change 7d-5.64%
YTD Performance-8.06%
SP500 benchmarkUnderperform
P/E16.62
P/S9.29
Revenue$52.25M
Earnings$20.42M
Dividend yield-
Main Sector
Healthcare
Category
Clinuvel Pharmaceuticals CUV Operating Margins
Operating Margin in 2022: 0.56%
According to Clinuvel Pharmaceuticals latest financial reports the company has an operating margin of 0.56%, an increase of 4.75% to 2022. At the end of 2022 company had an operating margin of 0.54%.
Clinuvel Pharmaceuticals Operating Margin from 2020 to 2024
-
Value:-
CUV Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 0.56% | 4.75% |
| 2022 | 0.54% | -8.63% |
| 2021 | 0.59% | 68.20% |
| 2020 | 0.35% | - |
View the highest operating margin companies 
